JCR Pharmaceuticals celebrating 50 years
On JCR Pharmaceuticals 50th anniversary, we are reflecting on where we started – six people in a tiny lab. It’s amazing to see how far we’ve come and the science we created in that time, including the development of our innovative platform technologies, J-Brain Cargo® and JUST-AAV gene therapy.
Looking ahead, we aim to continue producing unexpected breakthroughs. We hope you’ll follow our journey as we look ahead to the next 50 years, continuing to focus on patients around the world living with rare and genetic diseases.
Hear from some of our senior leadership team about JCR, our mission, and what we’ve accomplished over the last 50 years in the video.
JCR Pharmaceuticals announces launch of mucopolysaccharidosis (MPS) type II disease awareness film featured in The Next Frontier series
About this film:
JCR Pharmaceuticals presents a new film in The Next Frontier series, highlighting the story of a family impacted by mucopolysaccharidosis type II (MPS II or Hunter syndrome). The video shares the emotional and medical challenges faced by those living with this rare, life-threatening condition and underscores the importance of biotechnology in improving awareness and developing future treatments. The film premiered during the BIO International Convention 2025.
Download PDF below for full press release.